Plantaricin A, a cationic peptide produced by Lactobacillus plantarum, permeabilizes eukaryotic cell membranes by a mechanism dependent on negative surface charge linked to glycosylated membrane proteins

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 2, 2013, Pages 249-259

  Sand, Sverre L ^a   Nissen Meyer, Jon ^a   Sand, Olav ^a   Haug, Trude M ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Antimicrobial peptide; Ca2 + imaging; Cancer cell; Cell lysis; Electrophysiology; Electrostatic attraction

Indexed keywords

CALCIUM ION; CARBOHYDRATE; GLYCOSYLATED PROTEIN; MEMBRANE PROTEIN; PLANTARICIN A; POLYPEPTIDE ANTIBIOTIC AGENT; TRYPSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOLYSIS; EXTRACELLULAR CALCIUM; HYPOPHYSIS CELL; LACTOBACILLUS PLANTARUM; LIPID BILAYER; MEMBRANE BIOLOGY; MEMBRANE CONDUCTANCE; MEMBRANE PERMEABILIZATION; MICROFLUOROMETRY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; STATIC ELECTRICITY; SURFACE CHARGE;

ANIMALS; BACTERIOCINS; CALCIUM; CELL MEMBRANE PERMEABILITY; CYTOPHOTOMETRY; ELECTROPHYSIOLOGY; GLYCOSYLATION; LACTOBACILLUS PLANTARUM; MEMBRANE PROTEINS; PEPTIDES; PHOSPHOLIPIDS; PITUITARY GLAND, ANTERIOR; RATS; STATIC ELECTRICITY; SURFACE PROPERTIES; TRYPSIN;

EUKARYOTA; LACTOBACILLUS PLANTARUM; RATTUS;

EID: 84870164388     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2012.11.001     Document Type: Article

References (57)

1. H.M. Chen, K.W. Leung, N.N. Thakur, A. Tan, and R.W. Jack Distinguishing between different pathways of bilayer disruption by the related antimicrobial peptides cecropin B, B1 and B3 Eur. J. Biochem. 270 2003 911 920
2. G. Fimland, L. Johnsen, B. Dalhus, and J. Nissen-Meyer Pediocin-like antimicrobial peptides (class IIa bacteriocins) and their immunity proteins: biosynthesis, structure, and mode of action J. Pept. Sci. 11 2005 688 696
3. J. Nissen-Meyer, and I.F. Nes Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action Arch. Microbiol. 167 1997 67 77
4. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 2002 389 395
5. H.M. Chen, W. Wang, D. Smith, and S.C. Chan Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells Biochim. Biophys. Acta 1336 1997 171 179
6. J.S. Ye, X.J. Zheng, K.W. Leung, H.M. Chen, and F.S. Sheu Induction of transient ion channel-like pores in a cancer cell by antibiotic peptide J. Biochem. 136 2004 255 259
7. R.A. Cruciani, J.L. Barker, M. Zasloff, H.C. Chen, and O. Colamonici Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation Proc. Natl. Acad. Sci. U. S. A. 88 1991 3792 3796
8. L. Jacob, and M. Zasloff Potential therapeutic applications of magainins and other antimicrobial agents of animal origin Ciba Found. Symp. 186 1994 197 216
9. R.I. Lehrer, A.K. Lichtenstein, and T. Ganz Defensins: antimicrobial and cytotoxic peptides of mammalian cells Annu. Rev. Immunol. 11 1993 105 128
10. A. Lichtenstein Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane J. Clin. Invest. 88 1991 93 100
11. C. Leuschner, and W. Hansel Membrane disrupting lytic peptides for cancer treatments Curr. Pharm. Des. 10 2004 2299 2310
12. K. Andersland, G.F. Jolle, O. Sand, and T.M. Haug Peptide pheromone plantaricin A produced by Lactobacillus plantarum permeabilizes liver and kidney cells J. Membr. Biol. 235 2010 121 129
13. S.L. Sand, T.M. Haug, J. Nissen-Meyer, and O. Sand The bacterial peptide pheromone plantaricin A permeabilizes cancerous, but not normal, rat pituitary cells and differentiates between the outer and inner membrane leaflet J. Membr. Biol. 216 2007 61 71
14. S.L. Sand, C. Oppegard, S. Ohara, T. Iijima, S. Naderi, H.K. Blomhoff, J. Nissen-Meyer, and O. Sand Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells Peptides 31 2010 1237 1244
15. D.B. Diep, L.S. Havarstein, J. Nissen-Meyer, and I.F. Nes The gene encoding plantaricin A, a bacteriocin from Lactobacillus plantarum C11, is located on the same transcription unit as an agr-like regulatory system Appl. Environ. Microbiol. 60 1994 160 166
16. H.H. Hauge, D. Mantzilas, G.N. Moll, W.N. Konings, A.J. Driessen, V.G. Eijsink, and J. Nissen-Meyer Plantaricin A is an amphiphilic alpha-helical bacteriocin-like pheromone which exerts antimicrobial and pheromone activities through different mechanisms Biochemistry 37 1998 16026 16032
17. E.L. Anderssen, D.B. Diep, I.F. Nes, V.G. Eijsink, and J. Nissen-Meyer Antagonistic activity of Lactobacillus plantarum C11: two new two-peptide bacteriocins, plantaricins EF and JK, and the induction factor plantaricin A Appl. Environ. Microbiol. 64 1998 2269 2272
18. H. Zhao, R. Sood, A. Jutila, S. Bose, G. Fimland, J. Nissen-Meyer, and P.K. Kinnunen Interaction of the antimicrobial peptide pheromone plantaricin A with model membranes: implications for a novel mechanism of action Biochim. Biophys. Acta 1758 2006 1461 1474
19. P.E. Kristiansen, G. Fimland, D. Mantzilas, and J. Nissen-Meyer Structure and mode of action of the membrane-permeabilizing antimicrobial peptide pheromone plantaricin A J. Biol. Chem. 280 2005 22945 22950
20. G. Berge, L.T. Eliassen, K.A. Camilio, K. Bartnes, B. Sveinbjornsson, and O. Rekdal Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide Cancer Immunol. 59 2010 1285 1294
21. P. Marcato, C.A. Dean, C.A. Giacomantonio, and P.W. Lee Oncolytic reovirus effectively targets breast cancer stem cells Mol. Ther. 17 2009 972 979
22. P. Hunter The fourth front against cancer. The first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies EMBO Rep. 12 2011 769 771
23. R.E. Hancock, and D.S. Chapple Peptide antibiotics Antimicrob. Agents Chemother. 43 1999 1317 1323
24. K. Matsuzaki Magainins as paradigm for the mode of action of pore forming polypeptides Biochim. Biophys. Acta 1376 1998 391 400
25. Z. Oren, and Y. Shai Mode of action of linear amphipathic alpha-helical antimicrobial peptides Biopolymers 47 1998 451 463
26. Y. Shai Mode of action of membrane active antimicrobial peptides Biopolymers 66 2002 236 248
27. A. Tossi, L. Sandri, and A. Giangaspero Amphipathic, alpha-helical antimicrobial peptides Biopolymers 55 2000 4 30
28. I. Zelezetsky, S. Pacor, U. Pag, N. Papo, Y. Shai, H.G. Sahl, and A. Tossi Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity Biochem. J. 390 2005 177 188
29. B. Bechinger Rationalizing the membrane interactions of cationic amphipathic antimicrobial peptides by their molecular shape Curr. Opin. Colloid Interface 14 2009 349 355
30. B. Bechinger Insights into the mechanisms of action of host defence peptides from biophysical and structural investigations J. Pept. Sci. 17 2011 306 314
31. A. Marquette, A.J. Mason, and B. Bechinger Aggregation and membrane permeabilizing properties of designed histidine-containing cationic linear peptide antibiotics J. Pept. Sci. 14 2008 488 495
32. K. Balasubramanian, and A.J. Schroit Aminophospholipid asymmetry: a matter of life and death Annu. Rev. Physiol. 65 2003 701 734
33. K. Matsuzaki, K. Sugishita, N. Fujii, and K. Miyajima Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2 Biochemistry 34 1995 3423 3429
34. K. Matsuzaki Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes Biochim. Biophys. Acta 1462 1999 1 10
35. Y. Shai Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides Biochim. Biophys. Acta 1462 1999 55 70
36. S. Castano, B. Desbat, A. Delfour, J.M. Dumas, A. da Silva, and J. Dufourcq Study of structure and orientation of mesentericin Y105, a bacteriocin from Gram-positive Leuconostoc mesenteroides, and its Trp-substituted analogues in phospholipid environments Biochim. Biophys. Acta 1668 2005 87 98
37. T. Utsugi, A.J. Schroit, J. Connor, C.D. Bucana, and I.J. Fidler Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes Cancer Res. 51 1991 3062 3066
38. L.V. Rao, J.F. Tait, and A.D. Hoang Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity Thromb. Res. 67 1992 517 531
39. M. Sugimura, R. Donato, V.V. Kakkar, and M.F. Scully Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces Blood Coagul. Fibrinolysis 5 1994 365 373
40. P. Williamson, and R.A. Schlegel Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells Mol. Membr. Biol. 11 1994 199 216
41. R.V. Iozzo, R.P. Bolender, and T.N. Wight Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and stereologic analysis Lab. Invest. 47 1982 124 138
42. J. Kleeff, T. Ishiwata, A. Kumbasar, H. Friess, M.W. Buchler, A.D. Lander, and M. Korc The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer J. Clin. Invest. 102 1998 1662 1673
43. K. Matsuda, H. Maruyama, F. Guo, J. Kleeff, J. Itakura, Y. Matsumoto, A.D. Lander, and M. Korc Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells Cancer Res. 61 2001 5562 5569
44. B.P. Toole, T.N. Wight, and M.I. Tammi Hyaluronan-cell interactions in cancer and vascular disease J. Biol. Chem. 277 2002 4593 4596
45. C.Y. Fears, C.L. Gladson, and A. Woods Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells J. Biol. Chem. 281 2006 14533 14536
46. C.Y. Fears, and A. Woods The role of syndecans in disease and wound healing Matrix Biol. 25 2006 443 456
47. S. Munesue, Y. Kusano, K. Oguri, N. Itano, Y. Yoshitomi, H. Nakanishi, I. Yamashina, and M. Okayama The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones Biochem. J. 363 2002 201 209
48. H. Park, Y. Kim, Y. Lim, I. Han, and E.S. Oh Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells J. Biol. Chem. 277 2002 29730 29736
49. A.D. Theocharis, and D.A. Theocharis High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointestinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies Biomed. Chromatogr. 16 2002 157 161
50. A.D. Theocharis, M.E. Tsara, N. Papageorgacopoulou, D.D. Karavias, and D.A. Theocharis Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition Biochim. Biophys. Acta 1502 2000 201 206
51. M.E. Tsara, N. Papageorgacopoulou, D.D. Karavias, and D.A. Theocharis Distribution and changes of glycosaminoglycans in neoplasias of rectum Anticancer Res. 15 1995 2107 2112
52. A.H. Tashjian Jr., Y. Yasumura, L. Levine, G.H. Sato, and M.L. Parker Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone Endocrinology 82 1968 342 352
53. B. Fadnes, O. Rekdal, and L. Uhlin-Hansen The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells BMC Cancer 9 2009 183
54. B. Fadnes, L. Uhlin-Hansen, I. Lindin, and O. Rekdal Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells BMC Cancer 11 2011 116
55. F. Duchardt, I.R. Ruttekolk, W.P.R. Verdurmen, H. Lortat-Jacob, J. Burck, H. Hufnagel, R. Fischer, M. van den Heuvel, D.W.P.M. Lowik, G.W. Vuister, A. Ulrich, M. de Waard, and R. Brock A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency J. Biol. Chem. 284 2009 36099 36108
56. M.R. Yeaman, and N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55 2003 27 55
57. J.S. Mader, and D.W. Hoskin Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment Exp. Opin. Investig. Drugs 15 2006 933 946